PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients

Prostate Cancer and Prostatic Diseases

Volumn 11, Issue 2, 2008, Pages 148-152

  Serretta, V ^a   Catanese, A ^a   Daricello, G ^a   Liotta, R ^a   Allegro, R ^b   Martorana, A ^c   Aragona, F ^c   Melloni, D ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Department of Statistics   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DRUG TOLERABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATITIS; REFERENCE VALUE; TRANSRECTAL ULTRASONOGRAPHY; TREATMENT CONTRAINDICATION; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BIOPSY, NEEDLE; CIPROFLOXACIN; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; ORGAN SIZE; PALPATION; PATIENT SELECTION; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; RISK; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL; UNNECESSARY PROCEDURES;

EID: 43549101419     PISSN: 13657852     EISSN: 14765608     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500996     Document Type: Article

References (19)

1. Dalton DL. Elevated serum prostate-specific antigen due to acute bacterial prostatitis. Urology 1989; 33: 465-469.
2. Neal Jr DE, Clejan S, Sarma D, Moon TD. Prostate specific antigen and prostatitis. I. Effect of prostatitis on serum PSA in the human and nonhuman primate. Prostate 1992; 20: 105-111.
3. Game X, Vincendeau S, Palascak R, Milcent S, Fournier R, Houlgatte A. Total and free serum prostate specific antigen levels during the first month of acute prostatitis. Eur Urol 2003; 43: 702-705.
4. Hasui Y, Marutsuka K, Asada Y, Ide H, Nishi S, Osada Y. Relationship between serum prostate-specific antigen and histological prostatitis in patients with benign prostatic hyperplasia. Prostate 1994; 25 91-96.
5. Potts JM. Prospective identification of National Institutes of Health category IV prostatitis in men with elevated prostate specific antigen. J Urol 2000; 164: 1550-1553.
6. Irani J, Levillain P, Goujon JM, Bon D, Dore B, Aubert J. Inflammation in benign prostatic hyperplasia: Correlation with prostate specific antigen value. J Urol 1997; 157: 1301-1303.
7. Gerstenbluth RE, Seftel AD, Mac Lennan GT, Rao RN, Corty EW, Ferguson K et al. Distribution of chronic prostatitis in radical prostatectomy specimens with upregulation of bcl-2 in areas of inflammation. J Urol 2002; 167: 2267-2270.
8. Hochreiter W, Wolfensberger P, Danuser H, Studer UE. Antibiotic treatment of asymptomatic inflammatory prostatitis in patients with elevated psa: Can biopsies be avoided? Eur Urol 2004; 3 (Suppl 2): 204; Abstract 806.
9. Singh R, Cahill D, Popert R, O'Brien TS. Repeating the measurement of prostate-specific antigen in symptomatic men can avoid unnecessary prostatic biopsy. BJU Int 2003; 92: 932-935.
10. Nadler RB, Humphrey PA, Smith DS, Catalona WJ, Ratliff TL. Effect of inflammation and benign prostatic hyperplasia on elevated serum prostate specific antigen levels. J Urol 1995; 154: 407-409.
11. Brett S, Carver BS, Bozeman CB, Williams BJ, Venable DD. The prevalence of men with National Institutes of Health category IV prostatitis and association with serum prostate specific antigen. J Urol 2003; 169: 589-591.
12. Kwak C, Ku JH, Kim T, Park DW, Choi KY, Lee E et al. Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer. Urology 2003; 62: 854-859.
13. Bozeman CB, Carver BS, Eastham JA, Venable DD. Treatment of chronic prostatitis lowers serum prostate specific antigen. J Urol 2002; 167: 1723-1725.
14. Stancik I, Luftenegger W, Klimpfinger M, Muller MM, Hoeltl W. Effect of NIH-IV prostatitis on free and free-to-total PSA. Eur Urol 2004; 46: 760-764.
15. Jung K, Meyer A, Lein M, Rudolph B, Schnorr D, Loening SA. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate. J Urol 1998; 159: 1595-1598.
16. Scattoni V, Raber M, Montorsi F, Da Pozzo L, Brausi M, Calori G. Percent of free serum prostate-specific-antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia. Eur Urol 1999; 36: 621-630.
17. Lorente JA, Arango O, Bielsa O, Cortadellas R, Gelabert-Mas A. Effect of antibiotic treatment on serum PSA and percent free PSA levels in patients with biochemical criteria for prostate biopsy and previous lower urinary tract infections. Int J Biol Markers 2002; 17: 84-89.
18. Ornstein DK, Smith DS, Humprey PA, Catalona WJ. The effect of prostate volume, age, total prostate specific antigen level and acute inflammation on the percentage of free serum prostate specific antigen levels in men without clinically detectable prostate cancer. J Urol 1998; 159: 1234-1237.
19. Yavascaoglu I, Vuruskan H, Kordan Y, Cahskan Z, Oktay B. Effect of chronic inflammation of the prostate on ratio of free-to-total prostate specific antigen in serum. Eur Urol 2004; 3 (Suppl 2): 204; Abstract 805.